Cargando…
Treatment challenges for community oncologists treating postmenopausal women with endocrine-resistant, hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5076538/ https://www.ncbi.nlm.nih.gov/pubmed/27799819 http://dx.doi.org/10.2147/CMAR.S117274 |
| _version_ | 1782462039355031552 |
|---|---|
| author | Abdel-Razeq, Hikmat |
| author_facet | Abdel-Razeq, Hikmat |
| author_sort | Abdel-Razeq, Hikmat |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5076538 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | Dove Medical Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-50765382016-10-31 Treatment challenges for community oncologists treating postmenopausal women with endocrine-resistant, hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer Abdel-Razeq, Hikmat Cancer Manag Res Letter Dove Medical Press 2016-10-20 /pmc/articles/PMC5076538/ /pubmed/27799819 http://dx.doi.org/10.2147/CMAR.S117274 Text en © 2016 Abdel-Razeq. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
| spellingShingle | Letter Abdel-Razeq, Hikmat Treatment challenges for community oncologists treating postmenopausal women with endocrine-resistant, hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer |
| title | Treatment challenges for community oncologists treating postmenopausal women with endocrine-resistant, hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer |
| title_full | Treatment challenges for community oncologists treating postmenopausal women with endocrine-resistant, hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer |
| title_fullStr | Treatment challenges for community oncologists treating postmenopausal women with endocrine-resistant, hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer |
| title_full_unstemmed | Treatment challenges for community oncologists treating postmenopausal women with endocrine-resistant, hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer |
| title_short | Treatment challenges for community oncologists treating postmenopausal women with endocrine-resistant, hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer |
| title_sort | treatment challenges for community oncologists treating postmenopausal women with endocrine-resistant, hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5076538/ https://www.ncbi.nlm.nih.gov/pubmed/27799819 http://dx.doi.org/10.2147/CMAR.S117274 |
| work_keys_str_mv | AT abdelrazeqhikmat treatmentchallengesforcommunityoncologiststreatingpostmenopausalwomenwithendocrineresistanthormonereceptorpositivehumanepidermalgrowthfactorreceptor2negativeadvancedbreastcancer |